デフォルト表紙
市場調査レポート
商品コード
1745935

分子イメージングの世界市場:市場規模・シェア・動向、業界分析 (モダリティ別・用途別・最終用途別・地域別)、将来予測 (2025年~2034年)

Molecular Imaging Market Size, Share, Trends, Industry Analysis Report: By Modality, By Application, By End Use (Hospitals, Diagnostics Imaging Centers, and Research Institutes), and Region- Forecast, 2025-2034


出版日
ページ情報
英文 125 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
分子イメージングの世界市場:市場規模・シェア・動向、業界分析 (モダリティ別・用途別・最終用途別・地域別)、将来予測 (2025年~2034年)
出版日: 2025年05月01日
発行: Polaris Market Research
ページ情報: 英文 125 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、分子イメージングの市場規模は2034年までに139億7,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

分子イメージングとは、生体内の分子・細胞レベルの生物学的プロセスを可視化・測定する医療技術であり、早期かつ正確な疾患診断を可能にします。

政府や大学、非公開会社は、医療技術の研究開発(R&D)への投資を増やしています。このような投資は、科学者が新しいイメージング剤を発見し、既存のイメージング装置を改良するのに役立っています。また、より多くの資金が投入されることで、研究が実際の医療ツールになるまでのプロセスもスピードアップしています。その結果、より高度で効果的な分子イメージング製品が市場に出回るようになっています。このような技術革新への継続的な支援は、病気の診断や治療の新しい方法を開発するために不可欠であり、分子イメージングソリューションに対する需要は世界中で高まっています。

かつては、新しいイメージング薬剤や技術が臨床用に承認されるまでには何年もかかりました。しかし、FDAやEMAのような規制機関は現在、安全で効果的な製品をより早く市場に投入できるよう、そのプロセスを合理化しています。このような経路の改善は、企業が新しい分子イメージングツールを開発し、上市することを後押しします。承認が早まるということは、病院や診療所での採用が早まるということであり、患者が最新技術の恩恵をより早く受けられるようになります。このような規制当局の支援により、分子イメージング市場の革新と成長にとってより有利な環境が整いつつあります。

分子イメージング市場:分析概要

2024年には、ハイエンド機器と複雑な作業をこなす熟練した専門家が利用可能であることから、病院セグメントが分子イメージング市場を独占しました。

心血管セグメントは、世界の心血管疾患の有病率の上昇により、予測期間中に大きな成長が見込まれています。

2024年時点では、医療インフラが整備され、医療技術への投資が活発な北米が市場を独占しています。

アジア太平洋は、中国、日本、韓国などの国々における医療意識の高まり、投資の増加、医療インフラの拡大により、予測期間中に最も高いCAGRを記録すると予想されます。

世界の主要企業としては、ブルカー、キヤノンメディカルシステムズ、キュブレサ、GEヘルスケア、Koninklijke Philips N.V.、Mediso Ltd.、ポジトロン、島津製作所、シーメンス・ヘルティニアス、ユナイテッド・イメージング・ヘルスケアなどが挙げられます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 世界の分子イメージング市場の洞察

  • 市場スナップショット
  • 分子イメージングの市場力学
    • 促進要因と機会
      • 慢性疾患の有病率の上昇
      • 高齢化人口の増加
    • 抑制要因と課題
      • 初期コストが高め
    • 世論とプライバシーに関する判例
  • PESTEL分析
  • 分子イメージング市場の動向
  • バリューチェーン分析

第5章 世界の分子イメージング市場:モダリティ別

  • 主な分析結果
  • イントロダクション
  • 分子超音波イメージング
  • 陽電子放出断層撮影(PET)
  • 単一光子放出コンピュータ断層撮影(SPECT)
  • 核磁気共鳴(NMR)分光計
  • その他

第6章 世界の分子イメージング市場:用途別

  • 主な分析結果
  • イントロダクション
  • 心血管系
  • 神経学
  • 腫瘍
  • 呼吸器
  • 胃腸

第7章 世界の分子イメージング市場:最終用途別

  • 主な分析結果
  • イントロダクション
  • 病院
  • 診断画像センター
  • 研究機関

第8章 世界の分子イメージング市場:地域別

  • 主な分析結果
  • イントロダクション
    • 分子イメージング市場の分析:地域別 (2020~2034年)
  • 北米
    • 北米:モダリティ別(2020~2034年)
    • 北米:用途別(2020~2034年)
    • 北米:最終用途別(2020~2034年)
    • 米国
    • カナダ
  • 欧州
    • 欧州:モダリティ別(2020~2034年)
    • 欧州:用途別(2020~2034年)
    • 欧州:最終用途別(2020~2034年)
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋:モダリティ別(2020~2034年)
    • アジア太平洋:用途別(2020~2034年)
    • アジア太平洋:最終用途別(2020~2034年)
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ:モダリティ別(2020~2034年)
    • 中東・アフリカ:用途別(2020~2034年)
    • 中東・アフリカ:最終用途別(2020~2034年)
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ:モダリティ別(2020~2034年)
    • ラテンアメリカ:用途別(2020~2034年)
    • ラテンアメリカ:最終用途別(2020~2034年)
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 事業拡大・企業買収の分析
    • 事業拡大
    • 企業買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Bruker
  • Canon Medical Systems Corporation
  • Cubresa Inc.
  • GE HealthCare
  • Koninklijke Philips N.V.
  • Mediso Ltd.
  • Positron
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • United Imaging Healthcare Co., Ltd.
図表

List of Tables:

  • Table 1 Global Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 2 Global Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 3 Global Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 4 North America: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 5 North America: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 US: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 8 US: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 9 US: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 10 Canada: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 11 Canada: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 12 Canada: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Europe: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 14 Europe: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Europe: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 UK: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 17 UK: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 18 UK: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 France: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 20 France: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 21 France: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 22 Germany: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 23 Germany: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Germany: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Italy: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 26 Italy: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Italy: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 28 Spain: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 29 Spain: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 30 Spain: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 34 Russia: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 35 Russia: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Russia: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 China: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 44 China: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 45 China: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 46 India: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 47 India: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 48 India: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 52 Japan: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 53 Japan: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 54 Japan: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 58 South Korea: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 59 South Korea: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 60 South Korea: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Australia: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 62 Australia: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Australia: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 UAE: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 74 UAE: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 75 UAE: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 Israel: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 77 Israel: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 78 Israel: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 79 South Africa: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 80 South Africa: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 81 South Africa: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Latin America: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 86 Latin America: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 87 Latin America: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 88 Mexico: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 89 Mexico: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Mexico: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 91 Brazil: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 92 Brazil: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Brazil: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 94 Argentina: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 95 Argentina: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Argentina: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Molecular Imaging Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Modality
  • Figure 7. Global Molecular Imaging Market, by Modality, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Molecular Imaging Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Molecular Imaging Market, by End Use, 2024 & 2034 (USD Billion)
目次
Product Code: PM5682

The molecular imaging market size is expected to reach USD 13.97 billion by 2034, according to a new study by Polaris Market Research. The report "Molecular Imaging Market Size, Share, & Industry Analysis Report: By Modality, By Application, By End Use (Hospitals, Diagnostics Imaging Centers, and Research Institutes), and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Molecular imaging is a medical technique that visualizes and measures biological processes at the molecular and cellular levels within living organisms, enabling early and precise disease diagnosis.

Governments, universities, and private companies are investing more in research and development (R&D) for healthcare technologies. These investments are helping scientists discover new imaging agents and improve existing imaging machines. More funding also speeds up the process of turning research into real-world medical tools. As a result, more advanced and effective molecular imaging products are entering the market. This ongoing support for innovation is essential for developing new ways to diagnose and treat diseases, which increases the demand for molecular imaging solutions across the globe.

In the past, getting new imaging agents and technologies approved for clinical use could take many years. However, regulatory agencies such as the FDA and EMA are now streamlining their processes to help bring safe and effective products to market faster. These improved pathways encourage companies to develop and launch new molecular imaging tools. Faster approvals mean quicker adoption by hospitals and clinics, which helps patients benefit from the latest technologies sooner. This regulatory support is creating a more favorable environment for innovation and growth in the molecular imaging market.

Molecular Imaging Market Report Highlights

In 2024, the hospital segment dominated the molecular imaging market due to the availability of high-end equipment and skilled professionals to perform complex tasks.

The cardiovascular segment is expected to witness significant growth during the forecast period due to the rising prevalence of cardiovascular disease worldwide.

In 2024, North America dominated the market due to its well-established healthcare infrastructure and strong investments in medical technology.

Asia Pacific is expected to record the highest CAGR in the forecast period, driven by increasing healthcare awareness, rising investments, and expanding medical infrastructure in countries such as China, Japan, and South Korea.

A few global key market players are Bruker; Canon Medical Systems Corporation; Cubresa Inc.; GE HealthCare; Koninklijke Philips N.V.; Mediso Ltd.; Positron; Shimadzu Corporation; Siemens Healthineers AG; and United Imaging Healthcare Co., Ltd.

Polaris Market Research has segmented the molecular imaging market report on the basis of modality, application, end use, and region:

By Modality (Revenue - USD Billion, 2020-2034)

Molecular Ultrasound Imaging

Positron Emission Tomography (PET)

Single Photon Emission Computed Tomography (SPECT)

Nuclear Magnetic Resonance (NMR) Spectrometer

Others

By Application (Revenue - USD Billion, 2020-2034)

Cardiovascular

Neurology

Oncology

Respiratory

Gastrointestinal

By End Use (Revenue - USD Billion, 2020-2034)

Hospitals

Diagnostic Imaging Centers

Research Institutes

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Molecular Imaging Market Insights

  • 4.1. Molecular Imaging Market - Market Snapshot
  • 4.2. Molecular Imaging Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Chronic Disease
      • 4.2.1.2. Growing Geriatric Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Initial Cost
    • 4.2.3. Public opinion and privacy legal precedents
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Molecular Imaging Market Trends
  • 4.6. Value Chain Analysis

5. Global Molecular Imaging Market, by Modality

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
  • 5.3. Molecular Ultrasound Imaging
    • 5.3.1. Global Molecular Imaging Market, by Molecular Ultrasound Imaging, by Region, 2020-2034 (USD Billion)
  • 5.4. Positron Emission Tomography (PET)
    • 5.4.1. Global Molecular Imaging Market, by Positron Emission Tomography (PET), by Region, 2020-2034 (USD Billion)
  • 5.5. Single Photon Emission Computed Tomography (SPECT)
    • 5.5.1. Global Molecular Imaging Market, by Single Photon Emission Computed Tomography (SPECT), by Region, 2020-2034 (USD Billion)
  • 5.6. Nuclear Magnetic Resonance (NMR) Spectrometer
    • 5.6.1. Global Molecular Imaging Market, by Nuclear Magnetic Resonance (NMR) Spectrometer, by Region, 2020-2034 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Molecular Imaging Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Molecular Imaging Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Cardiovascular
    • 6.3.1. Global Molecular Imaging Market, by Cardiovascular, by Region, 2020-2034 (USD Billion)
  • 6.4. Neurology
    • 6.4.1. Global Molecular Imaging Market, by Neurology, by Region, 2020-2034 (USD Billion)
  • 6.5. Oncology
    • 6.5.1. Global Molecular Imaging Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 6.6. Respiratory
    • 6.6.1. Global Molecular Imaging Market, by Respiratory, by Region, 2020-2034 (USD Billion)
  • 6.7. Gastrointestinal
    • 6.7.1. Global Molecular Imaging Market, by Gastrointestinal, by Region, 2020-2034 (USD Billion)

7. Global Molecular Imaging Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Molecular Imaging Market, by Hospital, by Region, 2020-2034 (USD Billion)
  • 7.4. Diagnostic Imaging Centers
    • 7.4.1. Global Molecular Imaging Market, by Diagnostic Imaging Centers, by Region, 2020-2034 (USD Billion)
  • 7.5. Research Institutes
    • 7.5.1. Global Molecular Imaging Market, by Academic & Research Institutes, by Region, 2020-2034 (USD Billion)

8. Global Molecular Imaging Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Molecular Imaging Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Molecular Imaging Market - North America
    • 8.3.1. North America: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
    • 8.3.2. North America: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.4. Molecular Imaging Market - US
      • 8.3.4.1. US: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.3.4.2. US: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. US: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.5. Molecular Imaging Market - Canada
      • 8.3.5.1. Canada: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • 8.4. Molecular Imaging Market - Europe
    • 8.4.1. Europe: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.4. Molecular Imaging Market - UK
      • 8.4.4.1. UK: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.5. Molecular Imaging Market - France
      • 8.4.5.1. France: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.6. Molecular Imaging Market - Germany
      • 8.4.6.1. Germany: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.7. Molecular Imaging Market - Italy
      • 8.4.7.1. Italy: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.8. Molecular Imaging Market - Spain
      • 8.4.8.1. Spain: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.9. Molecular Imaging Market - Netherlands
      • 8.4.9.1. Netherlands: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.10. Molecular Imaging Market - Russia
      • 8.4.10.1. Russia: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.11. Molecular Imaging Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • 8.5. Molecular Imaging Market - Asia Pacific
    • 8.5.1. Asia Pacific: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.4. Molecular Imaging Market - China
      • 8.5.4.1. China: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.5. Molecular Imaging Market - India
      • 8.5.5.1. India: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.6. Molecular Imaging Market - Malaysia
      • 8.5.6.1. Malaysia: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.7. Molecular Imaging Market - Japan
      • 8.5.7.1. Japan: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.8. Molecular Imaging Market - Indonesia
      • 8.5.8.1. Indonesia: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.9. Molecular Imaging Market - South Korea
      • 8.5.9.1. South Korea: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.10. Molecular Imaging Market - Australia
      • 8.5.10.1. Australia: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.11. Molecular Imaging Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • 8.6. Molecular Imaging Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.4. Molecular Imaging Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.5. Molecular Imaging Market - UAE
      • 8.6.5.1. UAE: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.6. Molecular Imaging Market - Israel
      • 8.6.6.1. Israel: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.7. Molecular Imaging Market - South Africa
      • 8.6.7.1. South Africa: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.8. Molecular Imaging Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
  • 8.7. Molecular Imaging Market - Latin America
    • 8.7.1. Latin America: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.4. Molecular Imaging Market - Mexico
      • 8.7.4.1. Mexico: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.5. Molecular Imaging Market - Brazil
      • 8.7.5.1. Brazil: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.6. Molecular Imaging Market - Argentina
      • 8.7.6.1. Argentina: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.7. Molecular Imaging Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bruker
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Canon Medical Systems Corporation
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Cubresa Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. GE HealthCare
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Koninklijke Philips N.V.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Mediso Ltd.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Positron
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Shimadzu Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Siemens Healthineers AG
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. United Imaging Healthcare Co., Ltd.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development